Causes of death in long‐term bladder cancer survivors: A population‐based study

Introduction: In recent days, the relationship between gender, tumour stage and survival of bladder cancer has attracted interest. Materials and Methods: The Austrian cancer registry was linked to the national death statistics. All patients with urothelial cancer of the urinary bladder with stages pT1, pT2, pT3 and pT4 diagnosed between 1983 until 2012 were followed for up to 15 years. Overall and cancer-specific mortality were estimated by cumulative incidence. Results: A total of 27,773 patients were analysed. The male:female ratio declined from 3:1 for stage pT1-tumours (n = 16,416) to 2.6:1 for pT2 (n = 6,548), 2.1:1 for pT3 (n = 3,111) and 1.9:1 for pT4 (n = 1,698). The 5 years cumulative overall death rate for pT1 tumours was slightly lower for women (0.31 vs. 0.32; p = 0.016). The opposite was observed for more advanced tumour stages: pT2: women 0.66, men: 0.60 (p = 0.0001); pT3: women 0.76, men 0.72 (p = 0.0004) and for pT4: women 0.90, men 0.85 (p = 0.0001). Cancer-specific survival was identical for pT1-tumours in both sexes, while women had a worse cancer-specific survival in both age cohorts (<70 years and ≥70 years) with higher tumour stages. Conclusions: This population-based study demonstrates that (1) a rise of advanced bladder cancer stages in women and (2) that women with tumour stages >pT1 have a shorter cancer-specific and overall survival.

Download Full-text

Long-term cancer survivors experience work changes after diagnosis: results of a population-based study

Psycho-Oncology ◽

10.1002/pon.1522 ◽

2009 ◽

Vol 18 (12) ◽

pp. 1252-1260 ◽

Cited By ~ 58

Author(s):

Floortje Mols ◽

Melissa S.Y. Thong ◽

Gerard Vreugdenhil ◽

Lonneke V. van de Poll-Franse

Keyword(s):

Cancer Survivors ◽

Population Based ◽

Population Based Study

Download Full-text

Quality of life in long-term cervical cancer survivors: A population-based study

Gynecologic Oncology ◽

10.1016/j.ygyno.2012.12.033 ◽

2013 ◽

Vol 129 (1) ◽

pp. 222-228 ◽

Cited By ~ 52

Author(s):

Gwenael Le Borgne ◽

Mariette Mercier ◽

Anne-Sophie Woronoff ◽

Anne-Valérie Guizard ◽

Edwige Abeilard ◽

...

Keyword(s):

Quality Of Life ◽

Cervical Cancer ◽

Cancer Survivors ◽

Population Based ◽

Population Based Study

Download Full-text

Long-term outcomes of childhood cancer survivors in Sweden: A population-based study of education, employment, and income

Cancer ◽

10.1002/cncr.24840 ◽

2010 ◽

Vol 116 (5) ◽

pp. 1385-1391 ◽

Cited By ~ 67

Author(s):

Krister K. Boman ◽

Frank Lindblad ◽

Anders Hjern

Keyword(s):

Cancer Survivors ◽

Childhood Cancer ◽

Childhood Cancer Survivors ◽

Population Based ◽

Long Term Outcomes ◽

Population Based Study

Download Full-text

Exercise programming and counseling preferences in bladder cancer survivors: a population-based study

Journal of Cancer Survivorship ◽

10.1007/s11764-007-0010-5 ◽

2007 ◽

Vol 1 (1) ◽

pp. 27-34 ◽

Cited By ~ 46

Author(s):

Kristina H. Karvinen ◽

Kerry S. Courneya ◽

Peter Venner ◽

Scott North

Keyword(s):

Bladder Cancer ◽

Cancer Survivors ◽

Population Based ◽

Population Based Study

Download Full-text

Health and life insurance-related problems in very long-term cancer survivors in Germany: a population-based study

Journal of Cancer Research and Clinical Oncology ◽

10.1007/s00432-021-03825-x ◽

2021 ◽

Author(s):

Melissa S. Y. Thong ◽

Daniela Doege ◽

Linda Weißer ◽

Lena Koch-Gallenkamp ◽

Heike Bertram ◽

...

Keyword(s):

Cancer Survivors ◽

Cancer Diagnosis ◽

Population Based ◽

Additional Contribution ◽

Population Based Study ◽

Prostate Cancer Survivors ◽

Regional Population ◽

Prostate Cancers ◽

After Cancer

Abstract Purpose Limited research suggests that cancer survivors have problems with insurance. Our study aimed to gain insight into the proportion of very long-term (14–24 years post-diagnosis) survivors of breast, colorectal, and prostate cancers who had problems with health (HI) and life (LI) insurance. Methods We used data from CAESAR (CAncEr Survivorship—A multi-Regional population-based study). Participants completed questions on change in insurance providers since cancer diagnosis, problems with requesting (additional) HI or LI, and how potential problems were resolved. We conducted logistic regression to determine factors associated with change in statutory HI. Results Of the 2714 respondents, 174 (6%) reported having changed HI providers. Most switched between different statutory HI providers (86%), 9% from statutory to private, and 5% from private to statutory. Respondents who changed statutory HI providers were more likely to be prostate cancer survivors (OR 2.79, 95% CI 1.01–7.68) while being ≥ 65 years at time of diagnosis (OR 0.58, 95% CI 0.35–0.96) and having ≥ 2 comorbid conditions (OR 0.61, 95% CI 0.40–0.92) were associated with reduced odds for change. Problems in changing HI were minimal and were resolved with additional contribution. Of the 310 respondents who tried to get LI, 25 respondents reported having difficulties, of whom the majority had their request rejected. Conclusion Most cancer survivors did not change their HI nor tried to buy LI after cancer diagnosis. Problems with changing statutory HI were generally resolved with additional contribution while the main problem encountered when buying LI was rejection of request.

Download Full-text